Key facts
- OtoNexus Medical Technologies’s last known valuation is $44.2M (Oct 2021).
- It has raised $46.1M across 5 recorded rounds; the latest was Seed Round ($1.9M) in Dec 2021.
- Notable investors include US National Science Foundation, Impact Assets, MedTech Innovator, Keiretsu Forum, Catalytic Impact Foundation — 43 tracked in total.
- OtoNexus Medical Technologies has filed 10 Form Ds with the SEC since 2015, most recently Feb 2024 ($12.9M sold to 114 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 43 names
- ·Watchlist + deal alerts for OtoNexus Medical Technologies
Funding rounds
5 roundsAbout OtoNexus Medical Technologies
Developer of a medical device designed to diagnose middle ear infections in children and adults. The company's device applies a well-known medical technology, ultrasound, in a completely novel way to achieve a key advance in the detection of otitis media, enabling clinicians to identify viral or bacterial infection and determine whether an antibiotic is appropriate.
- Sector
- Healthcare
- HQ
- Bellevue, WA, United States
- Founded
- 2010
- Employees
- 22
- Website
- otonexus.com/
- Ownership
- Privately Held (backing)
OtoNexus Medical Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OtoNexus Medical Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OtoNexus Medical Technologies in its N-PORT filings yet. We sweep new filings monthly.